B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction

Nature Medicine

Volumn 19, Issue 10, 2013, Pages 1273-1280

  Zouggari, Yasmine ^a,b   Ait Oufella, Hafid ^a,b,c   Bonnin, Philippe ^b   Simon, Tabassome ^c,d   Sage, Andrew P ^e   Guérin, Coralie ^a,b   Vilar, José ^a,b   Caligiuri, Giuseppina ^a   Tsiantoulas, Dimitrios ^f,g   Laurans, Ludivine ^a,b   Dumeau, Edouard ^a,b   Kotti, Salma ^d   Bruneval, Patrick ^a,b,c   Charo, Israel F ^h   Binder, Christoph J ^f,g   Danchin, Nicolas ^c   Tedgui, Alain ^a,b   Tedder, Thomas F ⁱ   Silvestre, Jean Sébastien ^a,b   Mallat, Ziad ^a,e  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^h GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; CD20 ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 3; B CELL ACTIVATING FACTOR; CCL7 PROTEIN, MOUSE; TNFSF13B PROTEIN, MOUSE;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CARDIOVASCULAR RISK; CELL COMPARTMENTALIZATION; CELL INTERACTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DETERIORATION; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMORAL IMMUNE DEFICIENCY; LEUKOCYTE MOTILITY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; ANIMAL; BIOSYNTHESIS; BLOOD; HEART; HEART INFARCTION; HUMAN; LYMPHOCYTE DEPLETION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CHEMOKINE CCL7; HEART; HUMANS; LYMPHOCYTE DEPLETION; MICE; MONOCYTES; MYOCARDIAL INFARCTION; SIGNAL TRANSDUCTION;

EID: 84887439701     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3284     Document Type: Article

References (44)

1. White, H.D. & Chew, D.P. Acute myocardial infarction. Lancet 372, 570-584 (2008)
2. Jessup, M. & Brozena, S. Heart failure. N. Engl. J. Med. 348, 2007-2018 (2003)
3. McMurray, J.J. & Pfeffer, M.A. Heart failure. Lancet 365, 1877-1889 (2005)
4. Shah, A.M. & Mann, D.L. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378, 704-712 (2011)
5. Nabel, E.G. & Braunwald, E. A tale of coronary artery disease and myocardial infarction. N. Engl. J. Med. 366, 54-63 (2012)
6. Yellon, D.M. & Hausenloy, D.J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121-1135 (2007)
7. Taqueti, V.R., Mitchell, R.N. & Lichtman, A.H. Protecting the pump: controlling myocardial inflammatory responses. Annu. Rev. Physiol. 68, 67-95 (2006)
8. Zhang, M. et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 101, 3886-3891 (2004)
9. Zhang, M. et al. Identification of the target self-antigens in reperfusion injury. J. Exp. Med. 203, 141-152 (2006)
10. Zhang, M. et al. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J. Immunol. 177, 4727-4734 (2006)
11. Haas, M.S. et al. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc. Res. 87, 618-627 (2010)
12. Renner, B. et al. B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. J. Immunol. 185, 4393-4400 (2010)
13. Pepys, M.B. et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440, 1217-1221 (2006)
14. Salio, M. et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 117, 1055-1064 (2008)
15. Granger, D.N. & Korthuis, R.J. Physiologic mechanisms of postischemic tissue injury. Annu. Rev. Physiol. 57, 311-332 (1995)
16. Vinten-Johansen, J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 61, 481-497 (2004)
17. Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037-3047 (2007)
18. Leuschner, F. et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 209, 123-137 (2012)
19. Mahaffey, K.W. et al. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial. Circulation 108, 1176-1183 (2003)
20. Granger, C.B. et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation 108, 1184-1190 (2003)
21. Armstrong, P.W. et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. J. Am. Med. Assoc. 297, 43-51 (2007)
22. Eikelboom, J.W. & O'Donnell, M. Pexelizumab does not "complement" percutaneous coronary intervention in patients with ST-elevation myocardial infarction. J. Am. Med. Assoc. 297, 91-92 (2007)
23. Martin, F. & Chan, A.C. B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol. 24, 467-496 (2006)
24. Uchida, J. et al. Mouse CD20 expression and function. Int. Immunol. 16, 119-129 (2004)
25. Ait-Oufella, H. et al. B cell depletion reduces the development of atherosclerosis in mice. J. Exp. Med. 207, 1579-1587 (2010)
26. Hamaguchi, Y. et al. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J. Immunol. 174, 4389-4399 (2005)
27. Busche, M.N., Pavlov, V., Takahashi, K. & Stahl, G.L. Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin. Am. J. Physiol. Heart Circ. Physiol. 297, H1853-H1859 (2009)
28. Tsou, C.L. et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902-909 (2007)
29. Mackay, F. & Schneider, P. Cracking the BAFF code. Nat. Rev. Immunol. 9, 491-502 (2009)
30. Kelly-Scumpia, K.M. et al. B cells enhance early innate immune responses during bacterial sepsis. J. Exp. Med. 208, 1673-1682 (2011)
31. Rauch, P.J. et al. Innate response activator B cells protect against microbial sepsis. Science 335, 597-601 (2012)
32. Yilmaz, G., Arumugam, T.V., Stokes, K.Y. & Granger, D.N. Role of T lymphocytes and interferon-γ in ischemic stroke. Circulation 113, 2105-2112 (2006)
33. Burne-Taney, M.J. et al. B cell deficiency confers protection from renal ischemia reperfusion injury. J. Immunol. 171, 3210-3215 (2003)
34. Jang, H.R. et al. B cells limit repair after ischemic acute kidney injury. J. Am. Soc. Nephrol. 21, 654-665 (2010)
35. Goodchild, T.T. et al. Bone marrow-derived B cells preserve ventricular function after acute myocardial infarction. JACC Cardiovasc. Interv. 2, 1005-1016 (2009)
36. Kyaw, T. et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J. Immunol. 185, 4410-4419 (2010)
37. Sage, A.P. et al. BAFF receptor deficiency reduces the development of atherosclerosis in mice-brief report. Arterioscler. Thromb. Vasc. Biol. 32, 1573-1576 (2012)
38. Kyaw, T. et al. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLoS ONE 7, e29371 (2012)
39. Yanaba, K. et al. B-lymphocyte contributions to human autoimmune disease. Immunol. Rev. 223, 284-299 (2008)
40. Togbe, D. et al. Nonredundant roles of TIRAP and MyD88 in airway response to endotoxin, independent of TRIF, IL-1 and IL-18 pathways. Lab. Invest. 86, 1126-1135 (2006)
41. Kumar, D. et al. Distinct mouse coronary anatomy and myocardial infarction consequent to ligation. Coron. Artery Dis. 16, 41-44 (2005)
42. Scholz, J.L. et al. BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc. Natl. Acad. Sci. USA 105, 15517-15522 (2008)
43. Cochain, C. et al. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization. Cardiovasc. Res. 88, 186-195 (2010)
44. Simon, T. et al. Genetic determinants of response to clopidogrel and cardiovascular events. N. Engl. J. Med. 360, 363-375 (2009)